DD · 10-Q · 2026Q2 · Full report

NJ PFAS Settlement

DuPont de Nemours, Inc. · 2026-08-04 · Importance 40 · Surprise 42 · Matches filing data

In August 2025, DuPont, Chemours, and Corteva agreed to a proposed Judicial Consent Order with the State of New Jersey addressing legacy claims involving DNAPL, chemical solvents, PFAS, and other substances of concern. The settlement remains subject to approval by the Federal District Court of New Jersey in Camden and would be payable over 25 years, with DuPont’s initial payment due within 30 days after entry of the order. If approved, DuPont and Corteva will contribute $150 million to escrow, including $106.5 million from DuPont, while 44% of future funding obligations will be allocated to Qnity and indemnified by Qnity.

Key facts

• Contingent upon NJ Court approval, DuPont and Corteva will purchase Chemours’ interest in future insurance proceeds by contributing a total of $150 million ($106.5 million from DuPont, $43.5 million from Corteva) into an escrow fund. source
• The NJ Settlement agreed in August 2025 is payable over 25 years and DuPont's initial payment will be due within 30 days of the entry of the Judicial Consent Order by the NJ Court. source
• Pursuant to the Legacy Liabilities Assignment Agreement, 44 percent of any funding obligations related to the NJ Settlement will be contractually allocated to Qnity (and Qnity will indemnify the Company). source

Impact estimates